N/A
Completed N=74
Clinical Assessment of a Daily Wear Monthly Replacement Silicone Hydrogel Toric Contact Lens
Refractive errors · Astigmatism
Source: ClinicalTrials.gov NCT05211739 ↗
Enrolled (actual)
74
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcomePrimary: Distance Visual Acuity (VA) With Study Lenses — -0.06; -0.07; -0.08; -0.06 logMAR
Summary
The purpose of this clinical study is to assess the clinical performance of an investigational toric soft contact lens compared to a commercially available toric contact lens in a crossover dispense trial when worn in a daily wear modality for 30 days, each study lens type.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Distance Visual Acuity (VA) With Study Lenses |
-0.06; -0.07; -0.08; -0.06 | — |
Eligibility Criteria
Key Inclusion Criteria
- Successful wearers of weekly/monthly toric soft contact lenses in both eyes for a minimum of 5 days per week and 10 hours per day during the past 3 months;
- Best corrected distance visual acuity (as determined by manifest refraction at screening) better than or equal to 20/25 Snellen in each eye.
- Able to wear contact lenses within the range of available sphere & cylinder power and axes.
- Other protocol-defined inclusion criteria may apply.
Key Exclusion Criteria
- Daily disposable contact lens wearers.
- Monovision and multifocal contact lens wearers.
- Habitual Biofinity Toric/Biofinity Toric XR contact lens wearers in the past 3 months prior to consent.
- Other protocol-defined exclusion criteria may apply.
Data sourced from ClinicalTrials.gov (NCT05211739). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.